Division, U. S. COVID-19 Market Dashboard https://www.unicef.org/supply/covid-19-market-dashboard. (2024)
Kyriakidis, N. C., López-Cortés, A., González, E. V., Grimaldos, A. B. & Prado, E. O. SARS-CoV-2 vaccines strategies: a comprehensive review of phase 3 candidates. NPJ Vaccines 6, 28 (2021).
Article CAS PubMed PubMed Central Google Scholar
McDonald, I., Murray, S. M., Reynolds, C. J., Altmann, D. M. & Boyton, R. J. Comparative systematic review and meta-analysis of reactogenicity, immunogenicity and efficacy of vaccines against SARS-CoV-2. NPJ Vaccines 6, 74 (2021).
Article CAS PubMed PubMed Central Google Scholar
Zhang, L. et al. Effect of mRNA-LNP components of two globally-marketed COVID-19 vaccines on efficacy and stability. NPJ Vaccines 8, 156 (2023).
Article CAS PubMed PubMed Central Google Scholar
Krauson, A. J., Casimero, F. V. C., Siddiquee, Z. & Stone, J. R. Duration of SARS-CoV-2 mRNA vaccine persistence and factors associated with cardiac involvement in recently vaccinated patients. NPJ Vaccines 8, 141 (2023).
Article CAS PubMed PubMed Central Google Scholar
Gyöngyösi, M. et al. Effect of monovalent COVID-19 vaccines on viral interference between SARS-CoV-2 and several DNA viruses in patients with long-COVID syndrome. NPJ Vaccines 8, 145 (2023).
Article PubMed PubMed Central Google Scholar
Li, J. X. et al. Risk assessment of retinal vascular occlusion after COVID-19 vaccination. NPJ Vaccines 8, 64 (2023).
Article CAS PubMed PubMed Central Google Scholar
Heinz, F. X. & Stiasny, K. Distinguishing features of current COVID-19 vaccines: knowns and unknowns of antigen presentation and modes of action. NPJ Vaccines 6, 104 (2021).
Article CAS PubMed PubMed Central Google Scholar
Benkeser, D. et al. Immune correlates analysis of a phase 3 trial of the AZD1222 (ChAdOx1 nCoV-19) vaccine. NPJ Vaccines 8, 36 (2023).
Article CAS PubMed PubMed Central Google Scholar
Karbiener, M. et al. Calibrated comparison of SARS-CoV-2 neutralizing antibody levels in response to protein-, mRNA-, and vector-based COVID-19 vaccines. NPJ Vaccines 7, 22 (2022).
Article CAS PubMed PubMed Central Google Scholar
Azevedo, P. O. et al. Differential requirement of neutralizing antibodies and T cells on protective immunity to SARS-CoV-2 variants of concern. NPJ Vaccines 8, 15 (2023).
Article CAS PubMed PubMed Central Google Scholar
Diallo, B. K. et al. Intranasal COVID-19 vaccine induces respiratory memory T cells and protects K18-hACE mice against SARS-CoV-2 infection. NPJ Vaccines 8, 68 (2023).
Article CAS PubMed PubMed Central Google Scholar
Brumme, Z. L. et al. Humoral immune responses to COVID-19 vaccination in people living with HIV receiving suppressive antiretroviral therapy. NPJ Vaccines 7, 28 (2022).
Article CAS PubMed PubMed Central Google Scholar
Wang, Z. et al. A potent, broadly protective vaccine against SARS-CoV-2 variants of concern. NPJ Vaccines 7, 144 (2022).
Article CAS PubMed PubMed Central Google Scholar
Parry, H. et al. Extended interval BNT162b2 vaccination enhances peak antibody generation. NPJ Vaccines 7, 14 (2022).
Article CAS PubMed PubMed Central Google Scholar
Grigoryan, L. et al. Adjuvanting a subunit SARS-CoV-2 vaccine with clinically relevant adjuvants induces durable protection in mice. NPJ Vaccines 7, 55 (2022).
Article CAS PubMed PubMed Central Google Scholar
Nanishi, E. et al. Carbohydrate fatty acid monosulphate: oil-in-water adjuvant enhances SARS-CoV-2 RBD nanoparticle-induced immunogenicity and protection in mice. NPJ Vaccines 8, 18 (2023).
Article CAS PubMed PubMed Central Google Scholar
Xie, C., Yao, R. & Xia, X. The advances of adjuvants in mRNA vaccines. NPJ Vaccines 8, 162 (2023).
Article PubMed PubMed Central Google Scholar
Tioni, M. F. et al. Mucosal administration of a live attenuated recombinant COVID-19 vaccine protects nonhuman primates from SARS-CoV-2. NPJ Vaccines 7, 85 (2022).
Article CAS PubMed PubMed Central Google Scholar
Singh, C. et al. Phase III Pivotal comparative clinical trial of intranasal (iNCOVACC) and intramuscular COVID 19 vaccine (Covaxin(®)). NPJ Vaccines 8, 125 (2023).
Article CAS PubMed PubMed Central Google Scholar
Knisely, J. M. et al. Mucosal vaccines for SARS-CoV-2: scientific gaps and opportunities-workshop report. NPJ Vaccines 8, 53 (2023).
Article PubMed PubMed Central Google Scholar
Bartsch, Y. C. et al. BNT162b2 induces robust cross-variant SARS-CoV-2 immunity in children. NPJ Vaccines 7, 158 (2022).
Article CAS PubMed PubMed Central Google Scholar
Huang, L. et al. Comparing hybrid and regular COVID-19 vaccine-induced immunity against the Omicron epidemic. NPJ Vaccines 7, 162 (2022).
Article CAS PubMed PubMed Central Google Scholar
Ariën, K. K. et al. Three doses of BNT162b2 vaccine confer neutralising antibody capacity against the SARS-CoV-2 Omicron variant. NPJ Vaccines 7, 35 (2022).
Article PubMed PubMed Central Google Scholar
Lyke, K. E. et al. Immunogenicity of NVX-CoV2373 heterologous boost against SARS-CoV-2 variants. NPJ Vaccines 8, 98 (2023).
Article CAS PubMed PubMed Central Google Scholar
Zhao, F., Zai, X., Zhang, Z., Xu, J. & Chen, W. Challenges and developments in universal vaccine design against SARS-CoV-2 variants. NPJ Vaccines 7, 167 (2022).
Article CAS PubMed PubMed Central Google Scholar
Springer, D. N. et al. Bivalent COVID-19 mRNA booster vaccination (BA.1 or BA.4/BA.5) increases neutralization of matched Omicron variants. NPJ Vaccines 8, 110 (2023).
Article CAS PubMed PubMed Central Google Scholar
Ye, Q. et al. Rational development of a combined mRNA vaccine against COVID-19 and influenza. NPJ Vaccines 7, 84 (2022).
Article CAS PubMed PubMed Central Google Scholar
Williams, B. A., Jones, C. H., Welch, V. & True, J. M. Outlook of pandemic preparedness in a post-COVID-19 world. NPJ Vaccines 8, 178 (2023).
Article PubMed PubMed Central Google Scholar
Voigt, E. A. et al. A self-amplifying RNA vaccine against COVID-19 with long-term room-temperature stability. NPJ Vaccines 7, 136 (2022).
Article CAS PubMed PubMed Central Google Scholar
Kumar, V. M., Pandi-Perumal, S. R., Trakht, I. & Thyagarajan, S. P. Strategy for COVID-19 vaccination in India: the country with the second highest population and number of cases. NPJ Vaccines 6, 60 (2021).
Article CAS PubMed PubMed Central Google Scholar
Acharya, K. P., Ghimire, T. R. & Subramanya, S. H. Access to and equitable distribution of COVID-19 vaccine in low-income countries. NPJ Vaccines 6, 54 (2021).
Article CAS PubMed PubMed Central Google Scholar
Kreps, S., Dasgupta, N., Brownstein, J. S., Hswen, Y. & Kriner, D. L. Public attitudes toward COVID-19 vaccination: the role of vaccine attributes, incentives, and misinformation. NPJ Vaccines 6, 73 (2021).
Article CAS PubMed PubMed Central Google Scholar
Motta, M. Is partisan conflict over COVID-19 vaccination eroding support for childhood vaccine mandates? NPJ Vaccines 8, 5 (2023).
留言 (0)